Professional Documents
Culture Documents
Journal of Biotechnology
journal homepage: www.elsevier.com/locate/jbiotec
Center of Excellence for Shrimp Molecular Biology and Biotechnology (Centex Shrimp), Bangkok, Thailand
Department of Biotechnology, Faculty of Science, Mahidol University, Bangkok, Thailand
c
National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Thailand Science Park, Pathumthani, Thailand
d
National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Thailand Science Park, Pathumthani, Thailand
b
a r t i c l e
i n f o
Article history:
Received 15 March 2012
Received in revised form 20 April 2012
Accepted 23 April 2012
Available online 30 April 2012
Keywords:
Yellow head virus (YHV)
RNA interference (RNAi)
Chitosan
Quaternized chitosan
Non-viral vectors
Spodoptera frugiperda
a b s t r a c t
RNA interference (RNAi) is a promising strategy to combat shrimp viral pathogens at lab-scale experiments. Development of effective orally delivered agents for double-stranded (ds)RNA is necessary for
RNAi application at farm level. Since continuous shrimp cell lines have not been established, we are developing a dsRNA-delivery system in Spodoptera frugiperda (Sf9) cells for studying in vitro RNAi-mediated
gene silencing of shrimp virus. Sf9 cells challenged with yellow head virus (YHV) were used for validating
nanoparticles as effective dsRNA carriers. Inexpensive and biodegradable polymers, chitosan and its quarternized derivative (QCH4), were formulated with long dsRNA (>100 bp) targeting YHV. Their morphology
and physicochemical properties were examined. When treated with chitosan and QCH4dsRNA complexes, at least 50% reduction in YHV infection in Sf9 cells relative to the untreated control was evident at
24 h post infection with low cytoxicity. Inhibitory effects of chitosan and QCH4dsRNA complexes were
comparable to that of dsRNA formulated with Cellfectin , a commercial lipid-based transfection reagent.
The natural and quaternized chitosan prepared in this study can be used for shrimp virus-specic dsRNA
delivery in insect cultures, and have potential for future development of dsRNA carriers in shrimp feed.
2012 Elsevier B.V. All rights reserved.
1. Introduction
Chitosan and its derivatives as non-viral vectors have gained
tremendous interest for their applications, especially for gene
transfer and RNAi delivery systems. Chitosan can encapsulate
nucleic acids, both DNA and RNA, and form nanopolyplexes via
ionic interactions. The nanopolyplexes are low toxicity, biodegradable and biocompatibility (De Smedt et al., 2000; Koping-Hoggard
et al., 2001). Chemical modications and the ratio of positively
charged chitosan and negatively charged nucleic acids are introduced to optimize stability of the nanopolyplex. Several previous
studies demonstrated the capacity of chitosan or chitosan derivative to carry and deliver plasmid DNA and RNA both in vivo
and in vitro systems (Koping-Hoggard et al., 2001; Rojanarata
et al., 2008; Techaarpornkul et al., 2010; Weecharangsan et al.,
2008). However, applications of chitosan are still limited due to
its insolubility in neutral and basic pH. Moreover, its low specicity and transfection efciency of chitosan should be overcome
for its use in clinical trials (Kim et al., 2007). Quaternized chitosan
(QCH) was developed to improve solubility of natural chitosan at
pH 7. It was prepared by using commercially available Quat 188
under basic condition (Sajomsang et al., 2009a,b). The Quat 188
is an aqueous solution of N-(3-chloro-2-hydroxypropyl) trimethylammonium chloride (Xiao et al., 2012). It is well-known as a
quaternizing agent that introduce quaternary ammonium moiety
into the polymer backbone such as the one in starch (Heinze et al.,
2004), cellulose (Hashem et al., 2003), and chitosan (Sajomsang
et al., 2009a,b).
RNAi-based preventive approaches have shown promise against
shrimp viruses at lab-scale experiments. To date, intramuscularly
injection of dsRNA appears to be the most effective delivery method
for RNAi-mediated shrimp viral inhibition (Ongvarrasopone et al.,
2008; Saksmerprome et al., 2009; Tirasophon et al., 2007). There
remains a need to improve oral delivery method to make RNAimediated antiviral strategy feasible for shrimp farming. Due to the
lack of availability of continuous shrimp cell line, mosquito and
Spodoptera frugiperda 9 (Sf9) cell cultures have gained interest for
those who study shrimp-virus responses in molecular detail. They
have been reported to be immunopositive to white spot syndrome
virus (WSSV) and yellow head virus (YHV), suggesting likelihood of
shrimp viruses persistently replicating in insect cells (Sriton et al.,
98
2009; Gangnonngiw et al., 2010). The insect cells could be useful not
only for studying RNAi-mediated gene silencing of shrimp virus but
also for validating dsRNA carriers with promising inhibitory effects
prior to testing in shrimp.
In this study, chitosan and its quarternized derivatives are prepared as previously described (Sajomsang et al., 2009a,b), and
formulated with bacterially expressed dsRNA (>100 bp) targeting
YHV RNA-dependent RNA polymerase (RdRp) gene. Complex formations were analyzed by physicochemical methods. The aim of
this study is to evaluate transfection efcacy and cell toxicity of the
chitosanviral specic dsRNA complexes in an insect cell system.
The effective chitosan nanoparticles determined from this study
would have further applications in development of shrimp feed
containing viral specic dsRNA.
2. Materials and methods
2.1. Preparation of chitosan and QCH4
The chitosan, with average molecular weights (Mw ) of 276 was
purchased from Seafresh Chitosan (lab) Co., Ltd. in Thailand. The
degree of deacetylation (DDA) of chitosan was determined to be
94% by 1 H NMR spectroscopy (Lavertu et al., 2003). N-(3-Chloro2-hydroxypropyl) trimethylammonium chloride (Quat 188) was
obtained from the Dow Chemical Company in Thailand. A dialysis
tubing with Mw cut-off of 12,00014,000 g/mol from Cellu Sep T4,
Membrane Filtration Products, Inc., (Segiun, TX, USA) were used
to purify chitosan derivative. Chitosan was dispersed in 1% (w/v)
acetic acid to prepare the stock solution at a nal concentration of
1 g/l. QCH4 was synthesized by quaternizing chitosan with N-(3chloro-2-hydroxypropyl) trimethylammonium chloride (Quat 188)
(Sajomsang et al., 2009a,b).
2.2. Characterization of chitosan and QCH4
All attenuated total reectance Fourier transform infrared (ATRFTIR) spectra were collected with a Nicolet 6700 spectrometer
(Thermo Company, USA) using the single-bounce ATR-FTIR spectroscopy (Smart Orbit accessory) with a diamond internal reection
element (IRE) at the ambient temperature (25 C). These spectra were collected by using rapid-scan software in OMNIC 7.0
with 32 scans and a resolution of 4 cm1 . The 1 H NMR spectra
were measured on AVANCE AV 500 MHz spectrometer (Bruker,
Switzerland). All measurements were performed at 300 K, using
the pulse accumulation of 64 scans and LB parameter of 0.30 Hz.
D2 O/CD3 COOD and D2 O were used as the solvents for dissolving 5 mg of chitosan and QCH4, respectively. The weight average
molecular weight (Mw ), number average molecular weight (Mn ),
and Mw /Mn of chitosan and QCH4 were determined by using the
gel permeation chromatography (GPC). It consists of Waters 600E
Series generic pump, injector, ultrahydrogel linear columns (Mw
resolving range 120,000 kDa), guard column, pollulans as standard
(Mw 5.9788 kDa), and refractive index detector (RI). All samples
were dissolved in acetate buffer pH 4 and then ltered through
VertiPure nylon syringes lters 0.45 m (Vertical chromatography
Co., Ltd., Thailand). The mobile phases, 0.5 M AcOH and 0.5 M AcONa
(acetate buffer pH 4), were used at a ow rate of 0.6 ml/min at 30 C.
Then the injection volume 20 l was used.
QCH4 solution were mixed with 1 g of dsRNA solution. The complexes were formed through a self-assembly mechanism after
pipetting, and subsequently incubated at room temperature for
15 min before use. Different weight ratios of chitosandsRNA and
QCH4dsRNA complex were prepared to investigate dsRNA binding afnity by gel retardation. Physicochemical characterization
and morphological analysis of the obtained nanoplexes were then
examined. Hydrodynamic diameter, polydispersity index (PDI) and
zeta potential of nanopolyplexes were determined by the Photon Correlation Spectroscopy machine and electrophoretic mobility
titration (NanoZS4700 nanoseries, Malvern Instruments, UK). The
samples were obtained as the average of three measurements
at 25 C. For morphology investigation, 5 l of each of dsRNA,
chitosan, QCH4, chitosandsRNA complex and QCH4dsRNA complex were placed on a freshly cleaved mica surface, dried with a
stream of nitrogen, and further dried in an electronic dry cabinet at 25 C for 30 min. All samples were determined by atomic
force microscope (SPA400, Seiko, Japan) machine used the scanner
range 101000 nm area in tapping mode using a Micro cantilever
with 28 kHz resonance frequencies and a constant force, range of
1.41.8 N/m. All images were recorded in air at room temperature
and a scan speed of 0.8 Hz and the phase image and topology used
to determine the morphology and particle size.
2.4. Transfection of dsRNA into Sf9 cells using Cellfectin
(Invitrogen, USA) and chitosan nanopolyplexes
Sf9 cells were cultured in 2 ml of Sf-900 III SFM containing 1% antibiotic-antimycotic (pH 6.2) at a concentration of
5 105 cells/ml for 6-well plate (Costar, Corning, USA) and incubated at 28 C overnight or until 6070% cell conuency. Using
5 l Cellfectin , 2 g of dsRNA were transfected into Sf9 cells
by Cellfectin (Gibco Invitrogen, USA). The treated Sf9 cells were
incubated at 28 C for 12 h prior YHV infection. YHV stock was
prepared from hemolymph of YHV-infected shrimps as previously
described (Saksmerprome et al., 2009). Sf9 cells were infected with
YHV at a multiplicity of infection (MOI) of 20 or around 2 107
copies/well by incubating on a shaker at 28 C for 6 h. In the case of
chitosandsRNA complex, 10 l of complex which contains 2 g of
dsRNA was diluted in 1 ml Sf-900 III SFM without antibiotics prior
to transfection.
Cells were harvested at 12 h after transfection by centrifugation
at 2200 g for 5 min. Total RNAs were extracted by Tri-pure reagent
(Roche, USA). RNA concentrations were determined by UV spectroscopy at OD260 . First strand cDNA was prepared from 150 ng/l
of total RNA using Titan one tube reverse transcriptase (Roche,
USA) at 50 C for 30 min. Double-stranded RNA product in each
RNA sample was monitored by specic primer YHV invert F sal
(5 -ACGCGTCGACGCATGTCCTGTTCTC-3 ) and YHV reverse R pst
Actin-specic
primer
(5 -TTGACGTCGAATTCTAGCCATGC-3 ).
set, Actin-Sf9-Forward (5 -GATATGGAGAAGATCTGGCAC-3 ) and
Actin-Sf9-Reverse
(5 -ACGGGTCTGTTCCCTATGAAGCACCAC-3 ),
was added in PCR reaction for internal control. PCR conditions were
as followed: the initial denaturing step at 94 C, 2 min; denaturing
94 C, 30 s, annealing temperature depending on primers, 30 s,
extension at 72 C, 30 s for 30 cycles; and a nal extension at
72 C, 5 min. PCR products were analyzed using 1.5% agarose gel
electrophoresis.
2.5. Preparation of the FITC-conjugated QCH4 and transfection
99
Fig. 1. ChitosandsRNA and QCH4dsRNA complexes at various weight ratios. At weight ratios of chitosandsRNA 1.5 and QCH4dsRNA 0.2 were selected to study knockdown
efciency.
Fi = uorescence intensity of individual cell was measured by Olympus Fluoview version 1.7 viewer program (FV1000, Olympus,
Japan); i = 1, 2, 3, . . ., n; n = number of analyzed cells.
i=n Fi
F1 = F2 + F3 + + Fn
=
n
n
100
Fig. 2. Physicochemical property and morphology of complexes. (A) Size (), PDI () and zeta potential () of chitosan (QCH4)dsRNA complexes at different weight ratios.
(B) AFM images of (a) naked dsRNA, (b and c) Chitosan and its derivative, QCH4, (d) chitosandsRNA complex at weight ratio of 1.5 and (e) QCH4dsRNA complex at weight
ratio of 0.2.
Fig. 3. RT-PCR analysis. YHV-specic dsRNA were transfected in Sf9 cells using chitosan and its derivative (QCH4) as dsRNA carriers. Symbols a, b and c represent different
weight ratios of a carrier:dsRNA. In the case of native chitosan complex, a = 1.3, b = 1.5, and c = 1.7. For QCH4:dsRNA, shrimp actin was used as internal control for normalizing
RNA level. M: 2 log DNA marker, m: RNA from Sf9 cells without transfection, CF: RNA from dsRNA-transfected cells using Cellfectin as a transfectant and -: negative control
using DEPC water instead of RNA template.
101
Fig. 4. (A) Average YHV-antigen uorescence intensity from immunohistochemical staining of Sf9 cells using antibodies to structural protein of gp64 YHV. Cells were collected
at 12 (black bar) and 24 hpi (white bar) for determining the level of YHV infection. Error bars indicate the standard deviation. * and ** indicate signicant differences from
the pair-wise comparisons relative to the YHV-infected group at 12 and 24 hpi (p < 0.01), respectively. A.U. arbitrary unit. Immunohistochemistry assay of YHV-infected
cells at 12 (B) and 24 (C) hpi using a monoclonal antibody against YHV structural protein. Positive reactions are shown in red. (a) YHV infection only; (b) Cellfectin -dsRNA
transfection; (c) chitosandsRNA; (d) QCH4dsRNA. (For interpretation of the references to color in this gure legend, the reader is referred to the web version of this article.)
102
Fig. 4. (Continued ).
Table 1
Percentages of cell viability under different treatments determined by the trypan blue exclusion method. There are no signicant differences in all four groups
(p < 0.01).
Treatments
Untreated
Cellfectin -dsRNA
ChitosandsRNA
QHC4dsRNA
78.4 (3.2)
64.9(7.9)
74.0 (3.2)
73.9 (4.1)
4. Discussion
In the present work, dsRNA-mediated inhibition of shrimp viral
infection was investigated in Sf9 cells. Previous study by Sriton et al.
(2009) demonstrated that shrimp viruses, including YHV, can be
persistently maintained in Sf9 insect cell line. YHV can infect Sf9
cells, and its antigen is detected by immunohistochemistry using
monoclonal antibody (Y18) against antigen of envelope protein
(gp64) of YHV. General morphology of infected cells is not different from that of uninfected cells or mock cells under phase contrast
microscopy. Taken advantages of reproducibility and convenience,
shrimp virus-infected Sf9 cells can be used to screen for effective
dsRNA carriers, providing new approaches for RNAi applications in
shrimp.
103
Fig. 5. Confocal images of Sf9 cells incubated with FITC-labeled QCH4dsRNA complex at varying times. Upper and lower panels represent DIC (differential interference
contrast) images, and uorescent-FITC images, respectively. Red arrow indicates accumulation of FITC-labeled complexes in the cell. (For interpretation of the references to
color in this gure legend, the reader is referred to the web version of this article.)
104
Howard, K.A., Rahbek, U.L., Liu, X., Damgaard, C.K., Glud, S.Z., Andersen, M.O., Hovgaard, M.B., Schmitz, A., Nyengaard, J.R., Besenbacher, F., Kjems, J., 2006. RNA
interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. Molecular Therapy 14 (4), 476484.
Kim, T.H., Jiang, H.L., Jere, D., Park, I.K., Cho, M.H., Nah, J.W., Choi, Y.J., Akaike, T., Cho,
C.S., 2007. Chemical modication of chitosan as a gene carrier in vitro and in
vivo. Progress in Polymer Science 32, 726753.
Koping-Hoggard, M., Tubulekas, I., Guan, H., Edwards, K., Nilsson, M., Varum,
K.M., Artursson, P., 2001. Chitosan as a nonviral gene delivery system. Structureproperty relationships and characteristics compared with
polyethylenimine in vitro and after lung administration in vivo. Gene Therapy
8 (14), 11081121.
Lavertu, M., Xia, Z., Serreqi, A.N., Berrada, M., Rodrigues, A., Wang, D., Buschmann,
M.D., Gupta, A., 2003. A validated 1 H NMR method for the determination of the
degree of deacetylation of chitosan. Journal of Pharmaceutical and Biomedical
Analysis 32, 11491158.
Liu, X., Howard, K.A., Dong, M., Andersen, M.O., Rahbek, U.L., Johnsen, M.G., Hansen,
O.C., Besenbacher, F., Kiems, J., 2007. The inuence of polymeric properties on
chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials 28
(6), 12801288.
MacLaughlin, F.C., Mumper, R.J., Wang, J., Tagliaferri, J.M., Gill, I., Hinchcliffe, M., Rolland, A.P., 1998. Chitosan and depolymerized chitosan oligomers as condensing
carriers for in vivo plasmid delivery. Journal of Controlled Release 56 (13),
259272.
Ongvarrasopone, C., Chanasakulniyom, M., Sritunyalucksana, K., Panyim, S., 2008.
Suppression of PmRab7 by dsRNA inhibits WSSV or YHV infection in shrimp.
Marine Biotechnology (NY) 10 (4), 374381.
Rojanarata, T., Opanasopit, P., Techaarpornkul, S., Ngawhirunpat, T., Ruktanonchai,
U., 2008. Chitosan-thiamine pyrophosphate as a novel carrier for siRNA delivery.
Pharmaceutical Research 25 (12), 28072814.
Sajomsang, W., Gonil, P., Tantayanon, S., 2009a. Antibacterial activity of quaternary
ammonium chitosan containing mono or disaccharide moieties: preparation